Global X China Biotech ETF (HKG:2820)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
81.14
+3.14 (4.03%)
Sep 1, 2025, 3:58 PM HKT
4.03%
Assets572.64M
Expense Ratio0.68%
PE Ratio33.92
Dividend (ttm)n/a
Dividend Yieldn/a
Ex-Dividend Daten/a
Payout Frequencyn/a
Payout Ration/a
1-Year Return+89.85%
Volume73,016
Open78.20
Previous Close78.00
Day's Range77.98 - 81.34
52-Week Low40.72
52-Week High81.22
Beta0.79
Holdings30
Inception DateJul 25, 2019

About 2820

The Global X China Biotech ETF seeks to provide investment results that, before deduction of fees and expenses, closely correspond to the performance of the Underlying Index.

Asset Class Equity
Category Health Care
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2820
Provider Global X
Index Tracked Solactive China Biotech Index

Performance

2820 had a total return of 89.85% in the past year, including dividends. Since the fund's inception, the average annual return has been 8.25%.

Top 10 Holdings

68.87% of assets
NameSymbolWeight
WuXi AppTec Co., Ltd.60325910.04%
WuXi Biologics (Cayman) Inc.22699.33%
BeOne Medicines Ltd.ONC9.11%
Innovent Biologics, Inc.18019.02%
Jiangsu Hengrui Medicine Co., Ltd.6002768.74%
Akeso, Inc.99266.94%
Sino Biopharmaceutical Limited11775.90%
3SBio Inc.15303.87%
Hansoh Pharmaceutical Group Company Limited36923.14%
Shanghai RAAS Blood Products Co., Ltd.0022522.79%
View More Holdings